Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study

A. Marcon (Verona, Italy), P. Marchetti (Verona, Italy), J. Antó (Barcelona, Spain), L. Cazzoletti (Verona, Italy), I. Cerveri (Pavia, Italy), A. Corsico (Pavia, Italy), J. Garcia-Aymerich (Barcelona, Spain), J. Heinrich (Munich, Germany), D. Gislason (Reykjavik, Iceland), R. Jõgi (Tartu, Estonia), A. Johannessen (Bergen, Norway), B. Leynaert (Paris, France), A. Malinovschi (Uppsala, Sweden), I. Pin (Grenoble, France), J. Weyler (Antwerp, Belgium), C. Janson (Uppsala, Sweden), S. Accordini (Verona, Italy), D. Jarvis (London, United Kingdom)

Source: International Congress 2018 – Asthma in children and adults: long-term aspects
Session: Asthma in children and adults: long-term aspects
Session type: Oral Presentation
Number: 295
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Marcon (Verona, Italy), P. Marchetti (Verona, Italy), J. Antó (Barcelona, Spain), L. Cazzoletti (Verona, Italy), I. Cerveri (Pavia, Italy), A. Corsico (Pavia, Italy), J. Garcia-Aymerich (Barcelona, Spain), J. Heinrich (Munich, Germany), D. Gislason (Reykjavik, Iceland), R. Jõgi (Tartu, Estonia), A. Johannessen (Bergen, Norway), B. Leynaert (Paris, France), A. Malinovschi (Uppsala, Sweden), I. Pin (Grenoble, France), J. Weyler (Antwerp, Belgium), C. Janson (Uppsala, Sweden), S. Accordini (Verona, Italy), D. Jarvis (London, United Kingdom). Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study. 295

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reducing the decline of FEV1 after a 4-year therapy with montelukast in patients with bronchial asthma
Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD
Year: 2008


Long-term association of inhaled corticosteroids and long-acting β2-agonists with lung function decline in asthma: results from the ECRHS II
Source: Eur Respir J 2005; 26: Suppl. 49, 220s
Year: 2005

A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo
Source: Eur Respir J 2006; 28: Suppl. 50, 764s
Year: 2006

Observational study of inhaled corticosteroid treatment for improved expiratory variability index in steroid-naïve asthmatic children
Source: ERJ Open Res, 8 (1) 00499-2021; 10.1183/23120541.00499-2021
Year: 2022



Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
Source: ERJ Open Res, 8 (1) 00014-2022; 10.1183/23120541.00014-2022
Year: 2022



Obesity and the response to inhaled budesonide in patients with asthma
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007


Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020



Role of tiotropium in reducing exacerbations in COPD patients when added to long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS): The OUTPUL study
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Inhaled medication use in asthma and COPD Roma/Gypsies patients
Source: Eur Respir J 2005; 26: Suppl. 49, 610s
Year: 2005

Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis
Source: Eur Respir J 2004; 23: 552-558
Year: 2004



Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population
Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma
Year: 2007


Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial
Source: Eur Respir J 2007; 30: 457-466
Year: 2007



Asthma total costs reduction and clinical improvement after inhaled steroid shift to fluticasone propionate during 1 year in patients with moderate to severe asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 56s
Year: 2002

Meta-analysis of inhaled corticosteroids response in children with asthma.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019


Severe exacerbations, decline in lung function and inhaled budesonide in asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007

Inhaled corticosteroids in COPD: a case in favour
Source: Eur Respir J 2009; 34: 10-12
Year: 2009


FEV1 response to albuterol is not affected by inhaled human insulin (Exubera®) use in subjects with mild-to-moderate asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 840s
Year: 2006

Efficacy of tiotropium Respimat® in adults with moderate asthma, by baseline LTRA use
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015